◆英語タイトル:GenomeDx Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011708
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月13日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor aggressiveness to urologists and radiation oncologists. It also offers decipher genomics resource information database, a genomic expression database that helps for an open and interactive research collaboration and knowledge creation. GenomeDx works in partnership with cancer care and research organizations to develop its first test. The company operates through its research and development center and laboratory located in Vancouver, British Columbia Canada; and San Diego, California, the US. GenomeDx is headquartered in Vancouver, British Columbia, Canada.
GenomeDx Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
GenomeDx Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
GenomeDx Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
GenomeDx Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
GenomeDx Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
GenomeDx Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
GenomeDx Biosciences Inc, Medical Equipment, Deal Details 11
Venture Financing 11
GenomeDx Biosciences Raises USD4.9 Million in Financing 11
GenomeDx Biosciences Secures USD25.39 Million in Venture Funding 12
GenomeDx Biosciences Raises Funds Through Series B Financing 13
GenomeDx Biosciences Secures Investment In Series A Financing 14
Partnerships 15
GenomeDx Biosciences Expands Research Collaboration With Mayo Clinic 15
GenomeDx Biosciences Enters into Co-Marketing Agreement with Pathnostics 16
GenomeDx Biosciences Enters into Agreement with Color Genomics 17
Bostwick Labs Enters into Agreement with GenomeDx Biosciences 18
GenomeDx Biosciences Enters into Distribution Agreement with SouthGenetics 19
GenomeDx Biosciences Enters into Agreement with Sidney Kimmel Cancer Center 20
GenomeDx Expands Research Agreement with Mayo Clinic 21
GenomeDx Biosciences Inc – Key Competitors 22
GenomeDx Biosciences Inc – Key Employees 23
GenomeDx Biosciences Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
May 09, 2017: GenomeDx Appoints Michael Rodriguez as Chief Financial Officer 25
Legal and Regulatory 26
Jul 06, 2016: GenomeDx Biosciences Receives Accreditation from College of American Pathologists 26
Product News 27
Jun 01, 2017: GenomeDx’s Decipher to be Featured in Multiple Presentations at ASCO 2017 27
May 11, 2017: GenomeDx’s Decipher GRID Aids in Development and Validation of Molecular Subtypes in Prostate Cancer that Predict Response to Hormone Therapy 28
Feb 14, 2017: GenomeDx’s Decipher Prostate, GRID and Bladder Data to be Featured in Multiple Presentations at the 2017 Genitourinary Cancers Symposium 29
Sep 22, 2016: GenomeDx’s Decipher GRID and Decipher Tests to be Featured in Multiple Presentations at ASTRO 2016 32
03/15/2016: New Study Shows that Genetic Information from Prostate Needle Biopsy May Be Used to Predict Tumor Aggressiveness 35
03/08/2016: GenomeDx Biosciences Launches Decipher Biopsy Test 37
02/04/2016: GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy 38
01/07/2016: Academic Center Collaborations through GenomeDx’s Decipher GRID Help Drive New Understanding of Prostate Cancer Biomarkers 39
Other Significant Developments 41
Sep 13, 2016: GenomeDx Adds Multiple Leading Cancer Centers to Its Proprietary Genomics Resource Information Database Platform (Decipher GRID) 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
GenomeDx Biosciences Inc, Medical Equipment, Key Facts 2
GenomeDx Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
GenomeDx Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
GenomeDx Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
GenomeDx Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
GenomeDx Biosciences Inc, Deals By Market, 2011 to YTD 2017 9
GenomeDx Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
GenomeDx Biosciences Raises USD4.9 Million in Financing 11
GenomeDx Biosciences Secures USD25.39 Million in Venture Funding 12
GenomeDx Biosciences Raises Funds Through Series B Financing 13
GenomeDx Biosciences Secures Investment In Series A Financing 14
GenomeDx Biosciences Expands Research Collaboration With Mayo Clinic 15
GenomeDx Biosciences Enters into Co-Marketing Agreement with Pathnostics 16
GenomeDx Biosciences Enters into Agreement with Color Genomics 17
Bostwick Labs Enters into Agreement with GenomeDx Biosciences 18
GenomeDx Biosciences Enters into Distribution Agreement with SouthGenetics 19
GenomeDx Biosciences Enters into Agreement with Sidney Kimmel Cancer Center 20
GenomeDx Expands Research Agreement with Mayo Clinic 21
GenomeDx Biosciences Inc, Key Competitors 22
GenomeDx Biosciences Inc, Key Employees 23
GenomeDx Biosciences Inc, Other Locations 24
GenomeDx Biosciences Inc, Subsidiaries 24